Overview
AniTech Limited, a pre-clinical contract research organization (CRO), offers a full range of animal and cell-based testing services. This integrated approach ensures compliance with regulatory requirements set by government agencies such as the Food and Drug Administration (FDA) in the US, National Medical Products Administration (NMPA) in China and European Medicines Agency (EMA) in the European Union. We offer comprehensive testing services and regulatory filing documentation support for the efficacy and safety assessment of various products, including pharmaceuticals, medical devices, agricultural products, cosmetics, and supplementary health products. The company’s expertise and services extend to multiple industries, ensuring that clients can meet the necessary regulatory requirements. Furthermore, AniTech’s customizable pre-clinical studies services cater to the specific needs and requirements of clients, allowing for tailored testing protocols. This flexibility enables efficient and targeted evaluation of drug candidates while minimizing unnecessary costs.
Application of Our Technology
⋆ Novel Drug Screening
⋆ Safety and efficacy evaluation of novel or repurposed drugs
⋆ Safety screening for cosmetic and health supplement products
⋆ Safety evaluation for medical devices
⋆ Safety evaluation for food product and food packaging
Our Intellectual Property
Patent ID: 17/883,619
Awards
Local and International Recognitions
Gold Medal
Inventions Geneva
Silver Medal
Asia Exhibition of Innovations and Inventions Hong Kong
Hong Kong SciTech Pioneer Award
YLOT
Funding Support
We are proudly supported by these institutions
🌟HK Tech 300 Seed Fund
🌟HK Tech 300 Angel Fund
City University of Hong Kong
Technology Start-up Support Scheme for Universities (TSSSU)
Hong Kong Government Innovation and Technology Commission
Cyberport Creative Micro Fund (CCMF)
Cyberport Hong Kong
Cyberport Incubation Programme (CIP)
Cyberport Hong Kong